ReviewACS omega2025
Recent Advances in Electrically Stimulated Insulin Delivery Systems.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus has become one of the greatest medical challenges affecting millions of people globally. Non- and minimally invasive approaches for insulin release are currently being intensively investigated to improve the treatment efficacy and quality of life for diabetic patients. Electrically triggered drug release exhibits tremendous potential since it allows medications to be dosed intermittently on demand and over a long period of time using simple, safe, and inexpensive approaches. Despite such advantages, the use of electrical signals has been mainly focused on the delivery of small drugs, with the administration of protein-based drugs, such as insulin, being addressed only sporadically. However, in recent years, the controlled release of insulin through electrical stimulation has begun to be seriously studied, attracting interest because of its capacity to reduce the incidence of hyperglycemia, which further reduces the potential complications in diabetic patients. This review examines the state of the art of electroregulated insulin delivery systems, discussing the current different approaches existing and analyzing the advantages and disadvantages of each one of them.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.